查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1992386

注射用水生产系统市场：按类型、系统组件、技术类型、系统配置和最终用户划分－2026-2032年全球预测

Water for Injection Production System Market by Type, System Components, Technology Type, System Configuration, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，注射用水生产系统市场价值将达到 35.8 亿美元，到 2026 年将成长至 37.2 亿美元，到 2032 年将达到 52.4 亿美元，复合年增长率为 5.58%。

主要市场统计数据
基准年 2025 35.8亿美元
预计年份：2026年 37.2亿美元
预测年份 2032 52.4亿美元
复合年增长率 (%) 5.58%

为注射用水生产系统制定优先策略框架，将监管要求、业务永续营运和临床及商业生产中的资本规划连结起来。

本执行摘要概述了注射用水 (WFI) 生产系统的战略背景，并重点关注影响生命科学和医疗保健领域投资决策的关键营运、监管和技术优先事项。生产药用级注射用水需要融合严谨的工程设计、检验的製程控制和持续的风险管理，以维持注射给药所需的无菌性和内毒素控制。随着设施的现代化，相关人员要求系统能够兼顾可靠的微生物控制、节能运作和可预测的生命週期维护。

技术创新、更严格的法规和永续性要求如何重塑WFI製造供应商的价值提案和设施投资选择。

在技​​术进步、监管力度加大以及对永续性重视的推动下，注射用水（WFI）生产系统正经历着变革性的转变。膜技术的进步和新型热浓缩策略正在改变设计中的权衡取舍，从而在保持微生物控制的同时，提高回收率并降低能耗。同时，数位化引入了预测性维护和持续监控功能，提高了运转率和验证可追溯性，进而重塑了采购标准和服务模式。

评估 2025 年美国关税变化对 WFI 设备供应链重组、供应商多元化和筹资策略。

2025年美国关税政策的变化为全球供应链中的供应商和买家带来了新的成本考量。关税影响了进口设备和零件的经济效益，促使製造商重新评估筹资策略并评估其供应商网路的韧性。为此，采购团队扩大了供应商选择范围，包括寻找国内替代方案，并检验能够降低关税风险的製造结构。这种调整改变了前置作业时间的预期，并影响了有关零件标准化、备件库存管理和本地组装方案的决策。

将系统类型、组件优先顺序和最终用户采购因素连结起来的详细細項分析，可以製定有针对性的产品和服务策略。

关键的细分市场洞察揭示了技术规格、系统结构和最终用户需求如何驱动WFI生态系统中多样化的采购和整合策略。按类型划分，市场涵盖薄膜技术、多级蒸馏、逆渗透系统和蒸气压缩，这些差异体现在生命週期成本、能耗特征和验证方法上。依赖薄膜技术的系统通常优先考虑紧凑的面积和模组化设计，而当热稳定性和高纯度要求决定製程选择时，则需要多级蒸馏解决方案。

区域趋势和当地监管实践正在影响美洲、欧洲、中东和非洲以及亚太地区的部署模式、供应商策略和服务模式。

区域分析突显了法律规范、基础设施成熟度和医疗服务模式如何影响不同地区的技术采纳和服务预期。在美洲，对监管一致性的高度重视以及严格的验证要求，加上竞争激烈的供应商环境，推动了数位化监控和自动化在流程控制领域的快速应用。相较之下，欧洲、中东和非洲（EMEA）的需求则更为多样化，既有成熟的管理体制，也有优先考虑成本效益和在地化服务网络的新兴市场。这就要求供应商提供模组化、扩充性的解决方案和本地化的支援模式。

领先供应商如何透过结合检验的工程技术、服务生态系统和模组化解决方案来脱颖而出，从而确保长期伙伴关係和持续的业务收益。

企业层面的关键洞察凸显了领先供应商如何透过结合技术优势、卓越服务和伙伴关係模式来降低终端用户计划的复杂性，从而实现差异化竞争。顶级供应商透过将产品设计与强大的试运行和合格支援相结合，并提供可追溯的验证交付物和培训，加速了设施推出。许多製造商也在扩展售后服务，引入预测性维护计划和远端监控，以提高运作和延长设备使用寿命。这正在创建一个可持续的收入模式，使客户绩效与奖励紧密相关。

采购、工程和品质负责人可以采取切实可行的、高优先级的行动，以降低检验风险、提高运作和增强供应链韧性。

针对行业领导者的实用建议着重于协调技术、监管和商业性策略，以确保业务永续营运和竞争优势。首先，透过优先考虑降低验证复杂性并融入支援持续监控和快速诊断功能的设计，缩短调查週期。其次，修订筹资策略，对关键零件采用双重采购和近岸外包，以降低贸易和关税风险，同时确保合约中关于前置作业时间和备件供应的清晰度。

我们采用透明且可重复的研究途径，结合专家访谈、监管审查和技术整合，得出可操作且检验的产业见解。

本调查方法以对技术专家和从业人员的定性研究为基础，并辅以对监管指南、技术标准和公开技术文献的严格审查。主要工作流程包括对製程工程师、品质保证经理和设施计划经理进行结构化访谈，以收集关于系统选择标准、验证挑战以及整个生命週期服务预期的第一手观点。这些访谈内容被整合起来，以识别反覆出现的主题、风险点和基于最佳实践的风险缓解策略，并将这些内容纳入产品设计建议和采购清单中。

最终的综合分析重点强调了弹性系统设计、强大的供应商伙伴关係和前瞻性的生命週期策略——所有这些对于确保无菌生产的性能至关重要。

总之，注射用水生产系统仍是无菌产品製造中至关重要且需要精细控制的环节。近期技术、法规和贸易的发展进一步凸显了弹性设计、经验证的控制结构以及供应商透明度的重要性。相关人员必须平衡污染控制、运转率和能源效率等营运需求与供应链稳健性和检查准备等策略需求。成功的供应商将是那些能够提供整合解决方案的供应商，这些解决方案将成熟的技术性能与全生命週期服务相结合，从而简化合格并保持运作可靠性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：注射用水生产系统市场：依类型划分

  • 膜技术
  • 多级蒸馏
  • 逆渗透系统
  • 蒸气压缩

第九章 注射用水生产系统市场：依系统组件划分

  • 过滤装置
  • 泵浦
  • 储存槽

第十章：注射用水生产系统市场：依技术类型划分

  • 蒸髮型
  • 过滤类型

第十一章 依系统配置分類的注射用水生产系统市场

  • 独立版
  • 融合的

第十二章 注射用水生产系统市场：依最终用户划分

  • 生技公司
  • 合约研究机构
  • 医院和医疗机构
  • 製药

第十三章 注射用水生产系统市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 注射用水生产系统市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 注射用水生产系统市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国注射用水生产系统市场

第十七章：中国註射用水生产系统市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Aqua-Chem, Inc.
  • Asahi Kasei Corporation
  • BWT Holding GmbH
  • Donaldson Company, Inc.
  • Evoqua Water Technologies LLC
  • GE HealthCare Technologies Inc.
  • GEA Group
  • H2O GmbH
  • IDEX Corporation
  • MECO Incorporated
  • Merck KGaA
  • Pall Corporation by Danaher Corp.
  • Paul Mueller Company
  • Pentair plc
  • Sartorius AG
  • SPX Flow, Inc.
  • STERIS plc.
  • Stilmas SPA
  • SUEZ Water Technologies & Solutions
  • Sulzer Ltd.
  • Suncombe Limited.
  • Syntegon Technology GmbH
  • Thermo Fisher Scientific Inc.
  • Veolia Water Technologies
  • Xylem Inc.
Product Code: MRR-3204321AF10B

The Water for Injection Production System Market was valued at USD 3.58 billion in 2025 and is projected to grow to USD 3.72 billion in 2026, with a CAGR of 5.58%, reaching USD 5.24 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.58 billion
Estimated Year [2026] USD 3.72 billion
Forecast Year [2032] USD 5.24 billion
CAGR (%) 5.58%

A strategic framing of Water for Injection system priorities that links regulatory expectations, operational resilience, and capital planning across clinical and commercial manufacturing

This executive summary introduces the strategic context for Water for Injection production systems and frames the primary operational, regulatory, and technological priorities shaping investment decisions across life sciences and healthcare sectors. The production of pharmaceutical-grade water demands a confluence of engineering rigor, validated process controls, and ongoing risk management to maintain sterility and endotoxin control for parenteral applications. As facilities modernize, stakeholders seek systems that combine reliable microbiological control, energy-efficient operation, and predictable lifecycle maintenance.

The introduction emphasizes how capital project design interacts with quality frameworks, including system validation, change control, and Ongoing Product Quality Monitoring. It further highlights how procurement teams weigh total cost of ownership against operational resilience, driven by regulatory inspections and the imperative to minimize contamination risk. By connecting these operational priorities to the broader strategic aims of manufacturing continuity and patient safety, this section sets the stage for deeper analysis that follows. Transitional commentary prepares readers to move from framing to an assessment of shifting drivers and the implications for vendors, OEMs, and end users.

How technological innovation, regulatory intensification, and sustainability imperatives are reshaping supplier value propositions and facility investment choices in WFI production

The landscape for Water for Injection production systems is undergoing transformative shifts driven by technological advancement, tightening regulatory attention, and a growing emphasis on sustainability. Advances in membrane technologies and newer thermal concentration strategies are changing design trade-offs, enabling higher recovery and lower energy use while maintaining microbiological control. Concurrently, digitalization has introduced predictive maintenance capabilities and continuous monitoring that improve uptime and validation traceability, thereby reshaping procurement criteria and service models.

Regulatory agencies have heightened scrutiny of water systems as an integral part of sterile manufacturing, prompting more rigorous approaches to risk assessments, qualification protocols, and event investigation. These changes push manufacturers and their suppliers to adopt design-for-sterility principles and robust contamination control strategies. Moreover, a visible drive toward resource efficiency is prompting developers to prioritize solutions with lower water and energy footprints and improved scalability. Taken together, these shifts are altering supplier value propositions and changing how end users evaluate capital projects, making long-term operability and compliance readiness as critical as initial purchase cost.

Assessment of how the 2025 changes to United States tariffs prompted supply chain reconfiguration, sourcing diversification, and procurement strategy adjustments for WFI equipment

United States tariff policy changes in 2025 introduced new cost considerations for vendors and buyers operating within global supply chains. The tariffs affected the economics of imported equipment and components, prompting manufacturers to reassess sourcing strategies and to evaluate the resilience of their supplier networks. In response, procurement teams expanded supplier qualification activities to include domestic alternatives and to validate manufacturing that reduces exposure to tariff risk. This recalibration altered lead time assumptions and influenced decisions around component standardization, spares stocking, and local assembly options.

Beyond direct cost impacts, tariff-driven shifts triggered strategic responses from original equipment manufacturers and system integrators who adapted by localizing certain manufacturing steps or by redesigning systems to reduce dependency on tariff-exposed components. The result is a heightened focus on supply chain transparency, more rigorous contractual protections, and a rebalancing of total cost of ownership models to better reflect geopolitical and trade uncertainties. For organizations planning upgrades or new installations, the tariffs underscored the importance of scenario planning and of maintaining flexibility to pivot sourcing and service arrangements as trade environments evolve.

In-depth segmentation analysis linking system types, component priorities, and distinct end-user procurement drivers to inform targeted product and service strategies

Key segmentation insights reveal how technical specifications, system architecture, and end-user requirements drive divergent procurement and integration strategies across the WFI ecosystem. Based on Type, market is studied across Membrane Technology, Multiple Effect distillation, Reverse Osmosis system, and Vapor Compression, and these distinctions inform lifecycle costs, energy profiles, and validation approaches. Systems that rely on membrane technology typically emphasize compact footprint and modularity, whereas multiple effect distillation solutions are sought where thermal robustness and high-purity demands dictate process choice.

Based on System Components, market is studied across Filtration Units, Pumps, and Storage Tanks, and the performance and maintainability of these components determine microbial control outcomes and operational continuity. Filtration unit design impacts particle and bioburden management, pump reliability governs flow stability and redosing risks, and storage tank configuration affects stagnation control and cleaning regimes. Based on End User, market is studied across Biotech Companies, Contract Research Organizations, Hospitals & Healthcare Institutions, and Pharmaceutical, and each end user segment brings distinct procurement drivers. Biotech organizations often prioritize speed to clinic and modular scalability, CROs value flexible, mobile-capable systems, hospitals emphasize reliability and simplified maintenance for clinical settings, and large pharmaceutical companies require proven vendor track records and integrated qualification support. These segmentation lenses collectively guide vendors in tailoring technical roadmaps, service offerings, and commissioning packages to the specific needs of each buyer class.

Regional dynamics and localized regulatory practices that shape adoption patterns, vendor strategies, and service models across the Americas, EMEA, and Asia-Pacific

Regional insights highlight how regulatory frameworks, infrastructure maturity, and healthcare delivery models shape technology adoption and service expectations across broad geographies. Americas show a strong emphasis on regulatory alignment with advanced validation expectations and a competitive supplier landscape that drives rapid adoption of digital monitoring and automation for process control. In contrast, Europe, Middle East & Africa present a heterogeneous set of requirements where established regulatory regimes coexist with emerging markets that prioritize cost-effectiveness and localized service networks, prompting vendors to offer modular, scalable solutions and regional support models.

Asia-Pacific displays a diverse mix of high-capacity manufacturing hubs combined with rapidly expanding clinical infrastructure, creating demand for both large-scale thermal solutions and compact membrane-based systems for new facilities. Across these regions, sustainability and water-efficiency considerations are increasingly prominent, and local regulatory interpretations of pharmacopeial standards influence validation strategies and installation timelines. Consequently, vendors and integrators must calibrate their commercial models and support capabilities to align with region-specific procurement cycles, qualification expectations, and life-cycle service demands.

How leading vendors differentiate by combining validated engineering, service ecosystems, and modular solutions to secure long-term partnerships and recurring service revenues

Key company-level insights emphasize how leading suppliers differentiate through a combination of technology leadership, service excellence, and partnership models that reduce project complexity for end users. Top-tier vendors integrate product design with robust commissioning and qualification support, providing traceable validation artifacts and training that accelerate facility start-up. Many manufacturers are also expanding aftermarket services to include predictive maintenance programs and remote monitoring that improve uptime and extend equipment life while creating recurring revenue models that align incentives with customer performance.

Strategic collaborations have become more common as equipment providers partner with systems integrators, controls specialists, and component manufacturers to deliver turnkey solutions that simplify bidder selection and reduce interface risk. In parallel, some companies invest in modular product lines that support phased facility builds and easier scalability. The competitive landscape rewards firms that demonstrate consistent regulatory inspection readiness, strong service networks, and the ability to deliver lifecycle cost reductions through energy-efficient designs and simplified validation paths. These differentiators determine which suppliers win long-term contracts and secure strategic partnerships with high-value end users.

Practical and prioritized actions that procurement, engineering, and quality leaders can implement to reduce validation risk, improve uptime, and enhance supply chain resilience

Actionable recommendations for industry leaders focus on aligning technical, regulatory, and commercial strategies to secure operational continuity and competitive advantage. First, prioritize designs that reduce validation complexity and incorporate features that support continuous monitoring and rapid diagnostics to shorten investigation cycles. Second, reassess sourcing strategies to include dual-sourcing or nearshoring for critical components to mitigate trade and tariff exposure while maintaining contractual clarity on lead times and spare parts availability.

Third, invest in service models that combine remote monitoring with predictive analytics to move from reactive maintenance to condition-based interventions, thereby improving uptime and lowering lifecycle costs. Fourth, engage early with regulatory and quality teams during system selection to ensure that design choices support qualification plans and inspection readiness. Finally, foster cross-functional vendor partnerships that align product roadmaps with end-user needs for modularity, energy efficiency, and lifecycle support. By implementing these measures, organizations can reduce risk, accelerate commissioning, and capture greater operational predictability from their Water for Injection investments.

A transparent and reproducible research approach combining expert interviews, regulatory review, and technical synthesis to produce actionable and verifiable industry insights

The research methodology combines primary qualitative engagement with technical experts and practitioners, supplemented by a rigorous review of regulatory guidance, engineering standards, and publicly available technical literature. Primary workstreams included structured interviews with process engineers, quality assurance leads, and facility project managers to capture firsthand perspectives on system selection criteria, validation challenges, and lifecycle service expectations. These interviews were synthesized to identify recurring themes, risk points, and best-practice mitigations that inform both product design recommendations and procurement checklists.

Secondary analysis encompassed a review of regulatory guidance documents, pharmacopeial monographs, technical whitepapers, and vendor technical specifications to validate technical claims and to map technological trends against compliance requirements. Data triangulation ensured that insights reflected consistent patterns across multiple inputs and that recommendations addressed practical constraints observed in active projects. Throughout the methodology, emphasis was placed on transparency of assumptions, reproducibility of analytical steps, and the use of validated frameworks for supplier evaluation and risk assessment, enabling end users to adapt the approach to their internal governance processes.

Final synthesis highlighting the imperative for resilient system design, robust supplier partnerships, and proactive lifecycle strategies to secure sterile manufacturing performance

In conclusion, Water for Injection production systems remain a critical and sensitive element of sterile product manufacturing, and recent technological, regulatory, and trade developments have increased the importance of resilient design, validated controls, and supplier transparency. Stakeholders must balance operational imperatives-such as contamination control, uptime, and energy efficiency-with strategic requirements for supply chain robustness and inspection readiness. Vendors that succeed will be those that offer integrated solutions coupling proven technical performance with lifecycle services that simplify qualification and sustain operational reliability.

Looking ahead, organizations that proactively adopt modular designs, invest in monitoring and predictive maintenance, and align procurement strategies with risk mitigation principles will be best positioned to manage evolving compliance and commercial pressures. The synthesis presented here guides decision-makers toward pragmatic investments and partnership approaches that prioritize patient safety, facility resilience, and predictable operational outcomes. Accordingly, the insights set the groundwork for deeper analysis and tailored engagements to support specific program-level decisions and capital projects.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Water for Injection Production System Market, by Type

  • 8.1. Membrane Technology
  • 8.2. Multiple Effect distillation
  • 8.3. Reverse Osmosis system
  • 8.4. Vapor Compression

9. Water for Injection Production System Market, by System Components

  • 9.1. Filtration Units
  • 9.2. Pumps
  • 9.3. Storage Tanks

10. Water for Injection Production System Market, by Technology Type

  • 10.1. Evaporation-Based
  • 10.2. Filtration-Based

11. Water for Injection Production System Market, by System Configuration

  • 11.1. Standalone
  • 11.2. Integrated

12. Water for Injection Production System Market, by End User

  • 12.1. Biotech Companies
  • 12.2. Contract Research Organizations
  • 12.3. Hospitals & Healthcare Institutions
  • 12.4. Pharmaceutical

13. Water for Injection Production System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Water for Injection Production System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Water for Injection Production System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Water for Injection Production System Market

17. China Water for Injection Production System Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Aqua-Chem, Inc.
  • 18.6. Asahi Kasei Corporation
  • 18.7. BWT Holding GmbH
  • 18.8. Donaldson Company, Inc.
  • 18.9. Evoqua Water Technologies LLC
  • 18.10. GE HealthCare Technologies Inc.
  • 18.11. GEA Group
  • 18.12. H2O GmbH
  • 18.13. IDEX Corporation
  • 18.14. MECO Incorporated
  • 18.15. Merck KGaA
  • 18.16. Pall Corporation by Danaher Corp.
  • 18.17. Paul Mueller Company
  • 18.18. Pentair plc
  • 18.19. Sartorius AG
  • 18.20. SPX Flow, Inc.
  • 18.21. STERIS plc.
  • 18.22. Stilmas S.P.A.
  • 18.23. SUEZ Water Technologies & Solutions
  • 18.24. Sulzer Ltd.
  • 18.25. Suncombe Limited.
  • 18.26. Syntegon Technology GmbH
  • 18.27. Thermo Fisher Scientific Inc.
  • 18.28. Veolia Water Technologies
  • 18.29. Xylem Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY MULTIPLE EFFECT DISTILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY MULTIPLE EFFECT DISTILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY MULTIPLE EFFECT DISTILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY REVERSE OSMOSIS SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY REVERSE OSMOSIS SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY REVERSE OSMOSIS SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY VAPOR COMPRESSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY VAPOR COMPRESSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY VAPOR COMPRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY FILTRATION UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY FILTRATION UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY FILTRATION UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY STORAGE TANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY STORAGE TANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY STORAGE TANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY EVAPORATION-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY EVAPORATION-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY EVAPORATION-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY FILTRATION-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY FILTRATION-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY FILTRATION-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY STANDALONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY STANDALONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY STANDALONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY INTEGRATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY INTEGRATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY INTEGRATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY HOSPITALS & HEALTHCARE INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY HOSPITALS & HEALTHCARE INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY HOSPITALS & HEALTHCARE INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. GCC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GCC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. GCC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 111. GCC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. GCC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 113. GCC WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. G7 WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. G7 WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. G7 WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 129. G7 WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. G7 WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 131. G7 WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. NATO WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. NATO WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NATO WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 135. NATO WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. NATO WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 137. NATO WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY SYSTEM CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA WATER FOR INJECTION PRODUCTION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)